Cite
HARVARD Citation
Young, D. et al. (n.d.). P585 IBD Reference and Biosimilar adalimumab CroSS over Study (iBaSS): a mixed methods clinical trial of patients transitioning between originator and biosimilar adalimumab. Qualitative findings from an interim analysis presenting the patient perspective. Journal of Crohn's and colitis. pp. S537-S538. [Online].